FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104754673> ?p ?o ?g. }

• W3104754673 abstract "Abstract Background Type 2 diabetes represents an increasingly critical challenge for health policy worldwide. It absorbs massive resources from both patients and national economies to sustain direct costs of the treatment of type 2 diabetes and its complications and indirect costs related to work loss and wages. More recently, there are innovations based on remote control and personalised programs that promise a more cost-effective diabetes management while reducing diabetes-related complications. In such a context, this work attempts to update cost analysis reviews on type 2 diabetes, focusing on France and Germany, in order to explore most significant cost drivers and cost-saving opportunities through innovations in diabetes care. Although both countries approach care delivery differently, France and Germany represent the primary European markets for diabetes technologies. Methods A systematic review of the literature listed in MEDLINE, Embase and EconLit has been carried out. It covered interventional, observational and modelling studies on expenditures for type 2 diabetes management in France or Germany published since 2012. Included articles were analysed for annual direct, associated and indirect costs of type 2 diabetes patients. An appraisal of study quality was performed. Results were summarised narratively. Results From 1260 records, the final sample was composed of 24 papers selected according to predefined inclusion/exclusion criteria. Both France and Germany revealed a predominant focus on direct costs. Comparability was limited due to different study populations and cost categories used. Indirect costs were only available in Germany. According to prior literature, reported cost drivers are hospitalisation, prescriptions, higher HbA1c and BMI, treatment with insulin and complications, all indicators of disease severity. The diversity of available data and included costs limits the results and may explain the differences found. Conclusions Complication prevention and glycaemic control are widely recognized as the most effective ways to control diabetes treatment costs. The value propositions of self-based supports, such as hybrid closed-loop metabolic systems, already implemented in type 1 diabetes management, are the key points for further debates and policymaking, which should involve the perspectives of caregivers, patients and payers." @default.
• W3104754673 created "2020-11-23" @default.
• W3104754673 creator A5014952669 @default.
• W3104754673 creator A5033356488 @default.
• W3104754673 creator A5042850962 @default.
• W3104754673 creator A5043067724 @default.
• W3104754673 creator A5045046848 @default.
• W3104754673 creator A5063954373 @default.
• W3104754673 creator A5065775242 @default.
• W3104754673 creator A5080153540 @default.
• W3104754673 date "2020-11-16" @default.
• W3104754673 modified "2023-10-09" @default.
• W3104754673 title "Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies" @default.
• W3104754673 cites W1209690519 @default.
• W3104754673 cites W1549019148 @default.
• W3104754673 cites W1910578133 @default.
• W3104754673 cites W1968552143 @default.
• W3104754673 cites W1972329582 @default.
• W3104754673 cites W1974761774 @default.
• W3104754673 cites W1985756041 @default.
• W3104754673 cites W1989674525 @default.
• W3104754673 cites W2013340978 @default.
• W3104754673 cites W2020267609 @default.
• W3104754673 cites W2023046312 @default.
• W3104754673 cites W2031876951 @default.
• W3104754673 cites W2032239684 @default.
• W3104754673 cites W2034484377 @default.
• W3104754673 cites W2046175880 @default.
• W3104754673 cites W2054716136 @default.
• W3104754673 cites W2054931962 @default.
• W3104754673 cites W2061955175 @default.
• W3104754673 cites W2063735093 @default.
• W3104754673 cites W2066054102 @default.
• W3104754673 cites W2075474921 @default.
• W3104754673 cites W2094981153 @default.
• W3104754673 cites W2104928026 @default.
• W3104754673 cites W2105937589 @default.
• W3104754673 cites W2117272998 @default.
• W3104754673 cites W2119184132 @default.
• W3104754673 cites W2126938133 @default.
• W3104754673 cites W2135800910 @default.
• W3104754673 cites W2153213983 @default.
• W3104754673 cites W2160649531 @default.
• W3104754673 cites W2291036614 @default.
• W3104754673 cites W2338167986 @default.
• W3104754673 cites W2468310276 @default.
• W3104754673 cites W2551662664 @default.
• W3104754673 cites W2588741033 @default.
• W3104754673 cites W2734863879 @default.
• W3104754673 cites W2750674138 @default.
• W3104754673 cites W2773791657 @default.
• W3104754673 cites W2781555326 @default.
• W3104754673 cites W2789481148 @default.
• W3104754673 cites W2794134707 @default.
• W3104754673 cites W2803110059 @default.
• W3104754673 cites W2809110444 @default.
• W3104754673 cites W2809214319 @default.
• W3104754673 cites W2820285780 @default.
• W3104754673 cites W2883687605 @default.
• W3104754673 cites W2891400519 @default.
• W3104754673 cites W2891618874 @default.
• W3104754673 cites W2893949245 @default.
• W3104754673 cites W2895354013 @default.
• W3104754673 cites W2904963605 @default.
• W3104754673 cites W2906323567 @default.
• W3104754673 cites W2908526176 @default.
• W3104754673 cites W2912047032 @default.
• W3104754673 cites W2919203803 @default.
• W3104754673 cites W2930605434 @default.
• W3104754673 cites W2941874113 @default.
• W3104754673 cites W2950796007 @default.
• W3104754673 cites W2968463547 @default.
• W3104754673 cites W2971012801 @default.
• W3104754673 cites W3015175115 @default.
• W3104754673 cites W3034048069 @default.
• W3104754673 doi "https://doi.org/10.1186/s12913-020-05897-w" @default.
• W3104754673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7667793" @default.
• W3104754673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33198734" @default.
• W3104754673 hasPublicationYear "2020" @default.
• W3104754673 type Work @default.
• W3104754673 sameAs 3104754673 @default.
• W3104754673 citedByCount "14" @default.
• W3104754673 countsByYear W31047546732021 @default.
• W3104754673 countsByYear W31047546732022 @default.
• W3104754673 countsByYear W31047546732023 @default.
• W3104754673 crossrefType "journal-article" @default.
• W3104754673 hasAuthorship W3104754673A5014952669 @default.
• W3104754673 hasAuthorship W3104754673A5033356488 @default.
• W3104754673 hasAuthorship W3104754673A5042850962 @default.
• W3104754673 hasAuthorship W3104754673A5043067724 @default.
• W3104754673 hasAuthorship W3104754673A5045046848 @default.
• W3104754673 hasAuthorship W3104754673A5063954373 @default.
• W3104754673 hasAuthorship W3104754673A5065775242 @default.
• W3104754673 hasAuthorship W3104754673A5080153540 @default.
• W3104754673 hasBestOaLocation W31047546731 @default.
• W3104754673 hasConcept C121955636 @default.
• W3104754673 hasConcept C134018914 @default.
• W3104754673 hasConcept C137992405 @default.
• W3104754673 hasConcept C138816342 @default.
• W3104754673 hasConcept C142724271 @default.

• next